FY 2024 and Q1 2025 Corporate Update LikeFollowShareShare your feedbackQuestions (0)Post questionYour question will be visible to everyone.Start the conversationAsk Shield Therapeutics a question about this update.DiscoverShare your feedbackDiscover
